Literature DB >> 36097120

Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson's disease.

Nina Aghazadeh1, Elmira Aboutalebi Vand Beilankouhi2, Farima Fakhri3, Morad Kohandel Gargari4, Parisa Bahari5, Aliasghar Moghadami6, Zhila Khodabandeh7, Mohammad Valilo8.   

Abstract

Parkinson's disease (PD) is one of the most common neurological diseases, next only to Alzheimer's disease (AD) in terms of prevalence. It afflicts about 2-3% of individuals over 65 years old. The etiology of PD is unknown and several environmental and genetic factors are involved. From a pathological point of view, PD is characterized by the loss of dopaminergic neurons in the substantia nigra, which causes the abnormal accumulation of α-synuclein (α-syn) (a component of Lewy bodies), which subsequently interact with heat shock proteins (HSPs), leading to apoptosis. Apoptosis is a vital pathway for establishing homeostasis in body tissues, which is regulated by pro-apoptotic and anti-apoptotic factors. Recent findings have shown that HSPs, especially HSP27 and HSP70, play a pivotal role in regulating apoptosis by influencing the factors involved in the apoptosis pathway. Moreover, it has been reported that the expression of these HSPs in the nervous system is high. Apart from this finding, investigations have suggested that HSP27 and HSP70 (related to parkin) show a potent protective and anti-apoptotic impact against the damaging outcomes of mutant α-syn toxicity to nerve cells. Therefore, in this study, we aimed to investigate the relationship between these HSPs and apoptosis in patients with PD.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Apoptosis; Heat shock proteins; Lewy bodies; Neurodegenerative disease; Parkinson’s disease; α-synuclein

Year:  2022        PMID: 36097120     DOI: 10.1007/s11033-022-07900-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  83 in total

1.  Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity.

Authors:  Benjamin M Vincent; Daniel F Tardiff; Jeff S Piotrowski; Rebecca Aron; Matthew C Lucas; Chee Yeun Chung; Helene Bacherman; YiQun Chen; Michelle Pires; Radha Subramaniam; Dimple B Doshi; Heather Sadlish; Waseem K Raja; Eric J Solís; Vikram Khurana; Bertrand Le Bourdonnec; Robert H Scannevin; Kenneth J Rhodes
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

2.  Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism.

Authors:  Ji-feng Guo; Xue-wei Zhang; Li-luo Nie; Hai-nan Zhang; Bin Liao; Jing Li; Lei Wang; Xin-xiang Yan; Bei-sha Tang
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

Review 3.  Parkinson's Disease and Parkinsonism.

Authors:  Michael T Hayes
Journal:  Am J Med       Date:  2019-03-16       Impact factor: 4.965

4.  Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson's Disease.

Authors:  Ali Mota; Mohsen Hemati-Dinarvand; Ali Akbar Taheraghdam; Hamid Reza Nejabati; Ravan Ahmadi; Tohid Ghasemnejad; Milad Hasanpour; Mohammad Valilo
Journal:  Acta Neurol Taiwan       Date:  2019-09-15

5.  Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.

Authors:  Ken Nishimura; Masayuki Sano; Manami Ohtaka; Birei Furuta; Yoko Umemura; Yoshiro Nakajima; Yuzuru Ikehara; Toshihiro Kobayashi; Hiroaki Segawa; Satoko Takayasu; Hideyuki Sato; Kaori Motomura; Eriko Uchida; Toshie Kanayasu-Toyoda; Makoto Asashima; Hiromitsu Nakauchi; Teruhide Yamaguchi; Mahito Nakanishi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

Review 6.  Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.

Authors:  Daniel Savitt; Joseph Jankovic
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.

Authors:  Xuechao Gao; Marta Carroni; Carmen Nussbaum-Krammer; Axel Mogk; Nadinath B Nillegoda; Anna Szlachcic; D Lys Guilbride; Helen R Saibil; Matthias P Mayer; Bernd Bukau
Journal:  Mol Cell       Date:  2015-08-20       Impact factor: 17.970

9.  Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran.

Authors:  Samira Saedi; Mohsen Hemmati-Dinarvand; Haleh Barmaki; Zohreh Mokhtari; Hadis Musavi; Mohamad Valilo; Ali Mota; Soleiman Mahjoub
Journal:  Caspian J Intern Med       Date:  2021-03

Review 10.  Parkinson's Disease and the Environment.

Authors:  Nicole Ball; Wei-Peng Teo; Shaneel Chandra; James Chapman
Journal:  Front Neurol       Date:  2019-03-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.